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Abstract
Bacterial pathogens often manipulate host immune pathways to establish acute and chronic infection. Many Gram-negative
bacteria do this by secreting effector proteins through a type III secretion system that alter the host response to the
pathogen. In this study, we determined that the phage-encoded GogB effector protein in Salmonella targets the host SCF E3
type ubiquitin ligase through an interaction with Skp1 and the human F-box only 22 (FBXO22) protein. Domain mapping
and functional knockdown studies indicated that GogB-containing bacteria inhibited IkB degradation and NFkB activation
in macrophages, which required Skp1 and a eukaryotic-like F-box motif in the C-terminal domain of GogB. GogB-deficient
Salmonella were unable to limit NFkB activation, which lead to increased proinflammatory responses in infected mice
accompanied by extensive tissue damage and enhanced colonization in the gut during long-term chronic infections. We
conclude that GogB is an anti-inflammatory effector that helps regulate inflammation-enhanced colonization by limiting
tissue damage during infection.
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Introduction
Horizontal gene transfer (HGT) is an important contributor to
the genetic and phenotypic diversity of enteric bacteria. Plasmids
and genetic regions called pathogenicity islands (PAI) can provide a
fitness advantage and the ability to colonize and expand into novel
host niches [1]. HGT has been a major driver of evolution of
variousSalmonellaentericaserovars,givingrisetopathogensthatinfect
a wide range of cold and warm-blooded animal hosts. S. enterica is a
facultative intracellular pathogen that invades and replicates within
host cells. S. enterica serovar Typhimurium (S. Typhimurium) causes
food poisoning in humans characterized by diarrhea, abdominal
pain and fever. The acquisition of two pathogenicity islands,
Salmonella Pathogenicity Island-1 (SPI-1) and SPI-2, is considered a
major factor in the evolution of S. Typhimurium pathogenesis.
These genomic islands encode two different type III secretion
systems (T3SS-1 and T3SS-2) that deliver effector proteins into host
cells to manipulate host machinery leading to bacterial uptake,
growth, and dissemination. T3SS-1 promotes invasion of epithelial
cells, macrophage apoptosis and recruitment of phagocytes [2,3]
whereas T3SS-2 is primarily required for intracellular replication,
dissemination, and disease associated with systemic spread [4]. SPI-
1 and SPI-2 mutants are severely attenuated for virulence in mice
infections [5] indicating that their concerted activities profoundly
influence the host-pathogen interaction.
Acquisition of phage genes by lysogenic conversion contributed
to the genetic diversity of Salmonella by providing an extended
repertoire of virulence determinants that have integrated into
ancestral regulatory networks of the bacterial cell [6]. GogB is a
secreted effector encoded in the Gifsy-1 prophage found in some S.
enterica strains and is a substrate of both T3SS-1 and T3SS-2 [7].
We showed previously that GogB is a chimeric protein consisting
of an N-terminal canonical leucine-rich repeat domain (LRR) and
a C-terminal domain with similarity to known proteins. Salmonella
translocates GogB into the host cytoplasm, however its function
and host cell target(s) were not known. The LRR domain in GogB
resembles other LRR-containing effectors that function as a novel
class of E3 type ubiquitin ligases called NELs [8,9]. These include
the Salmonella effectors SspH1, SspH2, and SlrP, and the IpaH
family of proteins from Shigella.
The host ubiquitination system regulates a wide array of cellular
processes including growth and differentiation, gene expression,
and regulation of the host inflammatory response [10]. As such,
host ubiquitination is a well-known target of bacterial as well as
viral proteins [11,12,13,14]. For example, the Shigella effector
OspG binds to the Skp, Cullin, F-box containing complex (SCF)
component UbcH5 to inhibit IkBa degradation and NFkB
activation. In Legionella, interaction of the F-box protein AnkB
with SCF ligase promotes intracellular replication within the host
cell [12]. Viral pathogens among the Poxviridae family also target
the SCF complex indicating a widespread mechanism of
manipulating host cells during infection [14,15]. As well, Salmonella
exploits host ubiquitination pathways to regulate the temporal and
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[16,17,18]. Other NEL effectors act as ubiquitin ligases for certain
host cell targets [9].
The SCF complex is a multi-protein E3 ubiquitin ligase
catalyzing the ubiquitination of proteins fated for degradation.
The E3-type SCF
b-TrcP ligase complex regulates the NFkB
pathway by targeting ubiquitinated IkBa for degradation by the
proteasome [19]. The F-box domain is a ,50 amino acid motif
that mediates protein–protein interactions, often in concert with
other protein-protein interaction platforms such as LRRs. The F-
box motif interacts directly with the SCF protein Skp1 to bring
specific protein targets to the E3 ligase [20]. Humans have at least
38 genes encoding different F-box proteins, although most of their
functions and substrates are not known [21].
In this study, we identified the host cell target of the Salmonella
effector GogB to be F-box only protein 22 (FBXO22). We mapped
the FBXO22 interaction domain of GogB and showed that this
interaction targets GogB to the SCF ubiquitin ligase complex to
dampen the host inflammatory response by inhibiting IkBa
degradation and NFkB activation. Consistent with this, a gogB
mutant was hyper-inflammatory in the murine gut during chronic
infection with an accompanying increase in tissue pathology and
bacterial burden in gut tissue. We conclude that GogB is an anti-
inflammatory effector that dampens host inflammatory responses
following colonization in order to limit tissue damage and to
balance bacterial colonization levels during chronic infection.
Results
GogB interacts with the SCF ubiquitin ligase
Our previous work with GogB revealed an N-terminal LRR
domain with similarity to the LRR-containing Salmonella effectors
SspH1, SspH2, and SlrP and Shigella IpaH7.8/9 that have been
characterized as NEL proteins [7,8,9]. The NEL domain has a
conserved catalytic cysteine residue in the C-terminus that
mediates E3 ubiquitin ligase activity in vitro [8,22]. In order to
identify potential host cell targets of GogB, we immunoprecipitat-
ed GogB-HA that had been delivered into HeLa cells by Salmonella
via the T3SS (Fig. 1A). We identified three bands that co-purified
only with GogB-HA and mass spectrometry analysis identified
these proteins as lactate dehydrogenase, a-actin, and FBXO22, an
uncharacterized ,40 kDa human F-box-containing protein com-
ponent of the SCF ubiquitin ligase complex. To determine
whether the precipitated proteins specifically interacted with
GogB, the pull-down assay was repeated and we confirmed that
GogB specifically targeted FBXO22, whereas a-actin was a non-
specific contaminant of the pull-down (Fig. 1B). F-box proteins
function as the substrate recognition module of the E3-type SCF
ubiquitin ligase complex by binding to the adapter protein Skp1
[23] thereby targeting substrates for degradation [21]. To explore
the GogB-FBXO22 interaction further, we tested whether GogB
also interacts with Skp1. A pull-down assay with GST-GogB
mixed with lysates from either RAW264.7 or HeLa cells
confirmed that Skp1 also co-purified with GogB (Fig. 1C). The
Skp1 binding domain on GogB was identified by separately
expressing the GogB N-terminal LRR domain (amino acids 1–
253; gogB-NT) and the C-terminus encoding residues 254–497
(gogB-CT) and purifying each as GST fusions. GST pull-downs
with these GogB fragments showed that Skp1 bound to GogB-CT
but not to GogB-NT or GST alone (Fig. 1C). To verify this
interaction in host cells, GogB-NT and GogB-CT (the C-terminal
GogB fragment fused to the T3SS secretion signal [24]), were
expressed as HA-tagged proteins in a DgogB mutant and verified to
be secreted by the T3SS (Fig. S1). Similar to the GST pull-downs,
GogB and GogB-CT but not GogB-NT delivered to host cells by
the Salmonella T3SS interacted with a complex containing both
Skp1 and FBXO22 as denoted by the presence of both proteins in
lanes containing GogB and GogB-CT (Fig. 1D). Interestingly, we
only observed FBXO22 co-purifying with GogB when delivered
directly to host cells but not in GST pull downs with cell lysates
indicating that targeting FBXO22 by GogB is specific to the
infected host cell. These results demonstrate that GogB interacts
with the SCF ubiquitin ligase complex and that the C-terminal
domain of GogB mediates GogB-Skp1 and GogB-FBXO22
interactions. To determine whether Skp1 is required for the
binding of GogB to FBXO22, we performed RNA interference
experiments to knockdown the expression of Skp1 in HeLa cells.
Lysates from infected HeLa cells shows that Skp1 expression
was knocked down only in cells transfected with the Skp1 siRNA
but not control siRNA. Infection of these transfected cells with
DgogB complemented with the full-length GogB-2HA showed
that FBXO22 was precipitated by GogB-2HA in the absence or
presence of Skp1 (Fig. 1E). Pull-down assays were also
performed using cells infected with DgogB as a control for non-
specific binding. These results denote that GogB interacts with
Skp1 and FBXO22 using different binding domains and that a
GogB-FBXO22-Skp1 complex is formed in the host cells as
s h o w nb yt h ep r e s e n c eo fa l lt h r e ep r o t e i n si nt h ep u l l - d o w n
assay using GogB-HA-infected cells. Whether FBXO22 is
required for the binding of GogB to Skp1 remains to be
determined as our attempts to knock down FBXO22 expression
were not successful.
GogB contains an Fbox-like motif at the C-terminal
domain
F-box proteins typically bind to Skp1 through a ,50-amino
acid F-box motif. We examined whether GogB also binds to Skp1
through a similar domain. Bioinformatic analysis of GogB
identified an F-box-like domain between amino acids 270–334.
Alignment of the GogB F-box-like motif with sequences from
human F-box proteins b-Trcp1, Skp2, and the bacterial F-box
secreted effector GALA1 from Ralstonia solanacearum [25] showed a
Author Summary
Bacterial pathogens have evolved sophisticated ways to
subvert the innate defenses of their host. One way in
which pathogens do so is by blocking or dampening the
inflammatory response that is triggered once a microor-
ganism is detected by the innate immune system. In this
way, the microorganism can limit the activation of innate
defenses in the host to promote its own colonization and
dissemination. In this work we found that the enteric
human pathogen Salmonella enterica serovar Typhimur-
ium limits the activation of innate immune defenses in the
host by using a bacterial protein called GogB to interfere
with NFkB activation. NFkB is a key human transcription
factor involved in the expression of pro-inflammatory
cytokines during infection. In this infection situation,
Salmonella delivers GogB to the infected cell where it
interferes with ubiquitination of the NFkB inhibitor protein
called IkBa to prevent translocation of NFkB to the nucleus
where it would normally activate pro-inflammatory gene
expression. The anti-inflammatory property of GogB is
important for the bacteria to reach optimal infection
densities in host tissues and to actively limit the tissue
damage associated with prolonged inflammatory respons-
es.
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Mutation of these residues in human Skp2 F-box abolished its
interaction with Skp1 [26]. When we tested a GogB mutant
(D264–352) lacking the F-box-like domain it was severely
compromised in its ability to interact with Skp1 (Fig. 2B).
Although the amounts of GogB-CT and GogB LP270AA bound
to the HA-affinity beads were lower compared to that of full-
length GogB (lane 1), this did not affect the interaction of these
proteins with Skp1. In comparison, GogB-NT and GogB D264–
352 bound to the affinity beads at similar amounts compared to
GogB-CT or GogB LP270AA but these proteins did not
precipitate Skp1, demonstrating that the binding of Skp1 is
dependent on the F-box-like domain found at the C-terminus of
GogB. To determine if the conserved leucine-proline residues in
the GogB F-box-like domain were involved, we made alanine
substitutions in full-length GogB and GogB-CT. Introducing
L270A and P271A mutations in full-length GogB did not abolish
binding to Skp1 (Fig. 2B). Although L47A and P48A mutations
in GogB-CT appeared to reduce its interaction with Skp1, the
amount of GogB-CT bound to the affinity beads is lower. We
conclude from these results that GogB contains an F-box-like
domain that is essential for Skp1 binding and that multiple
determinants in this domain (perhaps including the conserved LP
motif) are involved in this interaction.
GogB interferes with IkBa degradation and NFkB
activation
The SCF
2bTRcP1 complex is important for NFkB activation
during the host inflammatory response because it targets the IkBa
inhibitor protein for ubiquitination and degradation [19,27].
Because other LRR-containing effector proteins are involved in
modulating NFkB activity during infection, we investigated a
potential role for GogB in the NFkB pathway through its
interaction with the SCF ligase complex. To do so, we infected
RAW264.7 cells with wild type and gogB-deficient Salmonella and
monitored levels of IkBa. Western blot analyses showed that the
amount of IkBa was lower in cell populations infected with a gogB
mutant compared to wild type Salmonella (Fig. 3A). Non-virulent
salmonellae have been shown to suppress the NFkB pathway by
inhibiting ubiquitination of IkBa, thereby modulating the
epithelial tissue response to inflammation [28]. To determine
whether the GogB-dependent decrease in IkBa was due to
ubiquitination and subsequent degradation, the level of poly-
ubiquitinated IkBa was determined by infecting macrophages with
wild type Salmonella, DgogB, and DgogB complemented with
plasmids encoding GogB or GogB-D264–352 in the presence or
absence of the proteasome inhibitor MG-132 to trap ubiquitinated
IkBa molecules. In the absence of proteasome inhibition it was
difficult to isolate ubiquitinated IkBa presumably due to its rapid
Figure 1. GogB interacts with FBXO22 and Skp1 of the SCF E3 ubiquitin ligase. A. Identification of GogB interacting partner in the host cell.
GogB-HA delivered to HeLa cells by wild type Salmonella was immunoprecipitated and associated proteins were separated by SDS-PAGE. A silver-
stained SDS-PAGE shows a ,40 kDa band identified as F-box only protein (FBXO22) by mass spectrometry (arrow). B. Western blot analysis of the
GogB-HA immunoprecipitation using antibodies against FBXO22 and actin. C. GogB interacts with the SCF ubiquitin ligase adapter protein Skp1
through the GogB C-terminus in a GST pull-down assay. GST-GogB and truncated GogB mutants encoding amino acid residues 1–253 (GogB-NT) and
254–497 (GogB-CT) were incubated with RAW 264.7 or HeLa cell lysates. Protein complexes were analyzed by Western blot using anti-Skp1 and anti-
GST antibodies. GST beads alone mixed with lysates were used as control for non-specific binding. D. GogB immunoprecipitates a complex consisting
of Skp1 and FBXO22 in host cells. GogB-HA or the truncation mutants were delivered to HeLa cells by the Salmonella T3SS and immunoprecipitated
from infected cell lysates. Bound proteins were analyzed by Western blot using anti-Skp1 and FBXO22 antibodies. E. GogB interacts with FBXO22 in
the absence of Skp1. HeLa cells were transfected with 80 pmol of either Skp1 siRNA or control siRNA. At 24 hr post-transfection, cells were infected
with DgogB or DgogB complemented with pgogB-2HA. Cell lysates were mixed with anti-HA affinity beads after 20 hr post-infection and bound
protein complexes were analyzed by Western blot using anti-Skp1, anti-FBXO22, and anti-HA antibodies. Anti-GAPDH was used as loading control for
lysates.
doi:10.1371/journal.ppat.1002773.g001
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MG-132, cells infected with DgogB or bacteria expressing the non-
functional GogBD264–352 mutant had higher levels of poly-
ubiquitinated IkBa in IkBa pull-downs compared to the wild type
strain. Complementation of DgogB with full-length GogB returned
the levels of poly-ubiquitinated IkBa to that in wild type (Fig. 3B).
These results suggested that GogB plays an essential role in down-
regulating the host inflammatory response during Salmonella
infection by inhibiting poly-ubiquitination of IkBa and thus
NFkB-dependent gene expression. To test the latter, we measured
NFkB-dependent expression of luciferase in RAW264.7 cells co-
transfected with pNFkB-luc and pCMV-bgal reporter plasmids.
Transfected cells were infected with wild type Salmonella containing
an empty vector or the DgogB mutant and DgogB complemented
with full-length gogB, or the mutant variants gogB-NT, gogB-CT,
gogB LP270AA, gogB-CT LP47AA, and gogBD264–352. Macrophag-
es infected with the gogB mutant had .10 fold higher luciferase
levels compared to cells infected with wild type Salmonella (Fig. 3C).
Deletion of the C-terminal domain previously shown to be the
active fragment, or deletion of the F-box motif inhibited this
NFkB-luciferase activity to ,4-fold that of wild type. Comple-
mentation of DgogB with the full-length GogB or the Skp1-
interacting domain, GogB-CT, resulted in NFkB-luciferase
activity similar to that of wild type. However, mutation of the
conserved leucine-proline residues in the F-box-like domain of
GogB resulted in only a slight increase in levels of NFkB activity
compared to wild type Salmonella denoting that other residues in
the F-box motif may be needed to inhibit host inflammatory
response, in keeping with our in vitro data with Skp1 interaction
using the same GogB mutant. These results show that GogB
partially blocks NFkB activation during Salmonella infection by
inhibiting IkBa degradation through its interaction with Skp1 and
that the GogB F-box-like domain is essential for this inhibitory
activity. These data also support the idea that other regions of
GogB, in addition to the F-box-like domain are involved in
inhibiting NFkB activity.
GogB inhibits IL1b production during infection
The functional relevance of the GogB-mediated decrease in
NFkB activity during Salmonella infection was examined first by
characterizing the inflammatory response of infected macrophag-
es. RAW264.7 cells were infected with wild type Salmonella, DgogB,
or complemented strains and interleukin-1b (IL1b) levels in culture
supernatants were measured. Similar to the NFkB luciferase assay
experiments, macrophages infected with wild type Salmonella or
DgogB complemented with full-length GogB or GogB-CT secreted
less IL1b compared to DgogB or the mutant complemented with
GogB-NT or GogBDFbox (Fig. 3D).
Skp1 is necessary for modulation of NFkBb ySalmonella
Previous work showed that the adapter protein Skp1 isessential for
NFkB signaling [19]. To examine whether the increased activity of
NFkB in cells infected with the gogB mutant was also dependent on
Skp1 or whether it was signaled through an alternate pathway, we
introduced the pNFkB-luc and pCMVbgal reporter plasmids into
HeLa cells and then knocked down Skp1 expression by RNA
interference (Fig. 3E and 3F). Thus, wild type S. Typhimurium and
the gogB mutants are unable to activate NFkB in the absence of Skp1.
Luciferase assays showed that knockdown of Skp1 expression in
host cells resulted in similar levels of NFkB activity upon infection
Figure 2. GogB contains an Fbox-like domain involved in Skp1 interaction. A. Amino acid sequence alignment of the putative Fbox-like
domain found at the C-terminus of GogB with the F-box consensus sequences (FBOX1 and FBOX2), the human F-box protein Skp2, and the secreted
effector GALA1 from the plant pathogen Ralstonia solanacearum. The conserved leucine and proline residues are highlighted in red and similar amino
acid residues are highlighted in blue boxes. B. Deletion of the GogB Fbox-like domain abrogates binding to Skp1 in vivo. HeLa cells were infected
with DgogB or DgogB expressing GogB, GogB-NT1–253, GogB-CT254–497, GogB-D264–352, a mutant with a deletion from residues 264–352, and the
mutants GogB LP-AA and GogB-CT LP-AA in which the conserved leucine and proline residues in the Fbox-like domain were mutated to alanine. At
20 hr post-infection, infected cells were lysed and lysates were incubated with anti-HA affinity beads and bound proteins were resolved by SDS-PAGE
and analyzed by Western blot using anti-Skp1 and anti-HA antibodies.
doi:10.1371/journal.ppat.1002773.g002
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wild-type SL1344/pWSK129. In contrast, treatment of HeLa cells
with control siRNA showed a 2 to 3 fold increase in NFkB activity
in cells infected with DgogB and strains complemented with gogB-
NT or strains with mutations in the F-box motif, gogB D264–352,
gogB LP270AA and gogB-CT LP47AA (Fig. 3E). Similar to the
luciferase assays performed using macrophages, DgogB comple-
mented with the full-length GogB or GogB-CT had similar NFkB
activity as wild-type cells containing an empty plasmid. Interest-
ingly, HeLa cells infected with GogB mutants complemented with
gogB LP270AA and gogB-CT LP47AA showed a higher NFkB level
compared to wild-type Salmonella. These results show that
differences in NFkB activation in cells infected with wild-type
Salmonella and DgogB are abolished in the absence of Skp1. Overall,
our results demonstrate that GogB plays a role in blocking the host
inflammatory response through inhibition of NFkB activation,
IkBa ubiquitination and degradation and that this modulation
requires the interaction of GogB with Skp1 of the SCF ubiquitin
ligase.
GogB does not affect Salmonella replication in
macrophages or during acute infection of susceptible
mice
Our results demonstrating the role of GogB in modulating the
host immune response through its interaction with the SCF ligase
led us to examine the role of this effector during acute and chronic
animal infections. We first performed gentamicin protection assays
to determine whether deletion of gogB impaired Salmonella
replication in macrophages and epithelial cells, which it did not,
as invasion at 2 h post-infection and replication after 20 h were
similar between the strains with and without GogB (Fig. 4A). This
suggested that the role of GogB might manifest in the context of
animal infection. To test this we used competitive acute infections
of susceptible C57BL/6 mice infected with a mixture of wild type
and DgogB Salmonella. Mutant and wild type bacteria were
recovered in equal numbers from gut tissues and systemic organs
after three days (Fig. 4B) indicating that deletion of gogB does not
significantly affect Salmonella fitness over acute infection periods in
genetically susceptible mice.
GogB influences colonization dynamics and modulates
inflammatory responses during infection of genetically
resistant mice
The Natural resistance-associated macrophage protein
(Nramp)-1 controls intracellular Salmonella growth by limiting the
transport of divalent cations across the bacterial vacuole [29].
Given that gogB-deficient Salmonella were not attenuated for acute
infection of susceptible mice we tested whether the GogB-
mediated modulation of the host inflammatory response contrib-
uted to chronic infection. We infected groups of Nramp1
+/+ mice
(129S1/SvImJ) with wild type or DgogB Salmonella and measured
bacterial colonization in systemic and intestinal sites at 4, 7, 39,
and 60 days after infection (Fig. 5). After four days, both wild type
and DgogB colonized the mice, however, mice infected with gogB-
deficient Salmonella had moderate but significantly higher bacterial
load in all tissues (p,0.05), with the largest effect seen in the
cecum. The DgogB-infected mice had enlarged mesenteric lymph
nodes (MLN) yet we did not observe outward signs of acute illness
such as hunching, ruffled fur or piloerection (data not shown). At
time points greater than 7 days there was no difference between
the number of wild type and mutant bacteria recovered from the
spleen or liver. However, what was striking was the high degree of
cecal colonization in mice infected with gogB-deficient Salmonella
throughout the long-term infection coupled with greater bacterial
load in the MLNs at day 60 (Fig. 5). Although the bacterial load
differences in the MLN at day 60 did not reach statistical
significance, all the DgogB-infected mice displayed a similar high
degree of colonization whereas colonization by wild type Salmonella
was more variable. From days 21 to 49, resistant mice are able to
clear Salmonella or eventually progress to a chronic carrier state
[30]. Indeed at day 60, very low numbers of wild type bacteria
were recovered from the cecum whereas DgogB mutants were
present at up to 5–6 log greater numbers, demonstrating a
profound difference between wild type and DgogB to persist in the
mouse cecum (Fig. 5). To gain preliminary insight into the
connection between bacterial load and inflammation, we treated
mice with dexamethasone as an immunosuppressant prior to
infection with Salmonella and monitored bacterial load in the cecum
at day 4 after infection (Fig. S2). In these experiments, the
Figure 3. GogB decreases the host inflammatory response by inhibiting IkBa degradation and NFkB activation. A. GogB inhibits IkBa
degradation during infection. RAW264.7 cells were infected with wild type and DgogB Salmonella and lysed after 4, 8, and 20 h. Lysates were probed
using anti-IkBa antibody. Actin was used as a loading control. B. Deletion of GogB or the Fbox-like domain on GogB increases ubiquitination of IkBa.
RAW 264.7 cells were infected with wild type Salmonella, DgogB,o rDgogB complemented with plasmid encoding GogB or GogB-D264–352 in the
presence (+) or absence (2) of the proteasome inhibitor MG-132. At 4 hr post-infection, cells were lysed and normalized by protein content. Levels of
ubiquitinated IkBa were determined by a co-immunoprecipitation assay using IgA magnetic beads coupled to anti-IkBa antibodies and mixed with
the lysates. Western blot was done using HRP-conjugated anti-ubiquitin (FK2) and rabbit anti-IkBa. C. GogB-deficient Salmonella induce higher NFkB
activation compared to wild type. RAW264.7 were transfected with a luciferase reporter and then infected with wild type Salmonella containing an
empty pWSK129 vector, DgogB, and DgogB strains complemented with plasmids encoding full-length GogB, GogB-NT1–253, GogB-CT254–497, GogB
LP270AA, GogB-CT254–497 LP47AA, and GogB-D265–352. At 20 hr post-infection, NFkB-driving luciferase activity was measured and normalized to b-
galactosidase levels and CFUs enumerated from each strain after infection. Data are expressed as mean fold difference in NFkB levels compared to
cells infected with wild-type SL1344/pWSK129 with standard errors from three independent experiments. D. Deletion of GogB increases IL1b
activation in infected macrophages. RAW264.7 cells were infected with wild type Salmonella containing an empty pWSK129 vector, DgogB,o rDgogB
complemented with plasmids encoding GogB, GogB-NT, GogB-CT, GogB LP270AA, GogB-CT254–497 LP47AA, and GogB-D264–352. At 20 hr post-
infection, IL1b levels were measured in culture supernatants of infected macrophages by ELISA and normalized to CFUs enumerated from each strain
at 20 h post-infection. Data are expressed as mean IL1b concentration (pg/mL) with standard errors from three independent experiments. Asterisks
denote significant difference between the indicated strains, P,0.01. E. NFkB activation in DgogB-infected epithelial cells is blocked in the absence of
Skp1. HeLa cells co-transfected with 2 pmol Skp1 siRNA or negative control siRNA, and a luciferase gene reporter system. At 24 hr post-transfection,
cells were infected with wild-type Salmonella, DgogB or the complemented mutant strains. NFkB activation was determined by reporter gene assay
after 20 hr post-infection. Values are normalized to b-galactosidase levels and CFUs enumerated from each strain after infection. Data are expressed
as mean fold difference in NFkB levels compared to cells infected with wild-type Salmonella containing an empty vector. Assays were done in
triplicate in three independent experiments (n=3, 6 SEM). F. Representative Western blot analysis showing knockdown of Skp1 expression in HeLa
cells transfected with Skp1 or control siRNA and NFkB reporter assay and infected with wild-type SL1344/pWSK129, DgogB or DgogB complemented
strains. Lysates were normalized by protein content and analyzed by Western blot using anti-Skp1 and anti-GAPDH as loading control.
doi:10.1371/journal.ppat.1002773.g003
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immunosuppressed mice and similar to the levels of wild-type
bacteria in the cecum during dexamethasone treatment. These
data suggested to us that the gogB mutant does not have an
inherent increased growth rate leading to increased inflammation,
but rather benefits from a heightened inflammatory response that
is suppressible by chemical blockade.
Histopathological analysis revealed a marked difference in tissue
inflammation and integrity of the cecal tissue in mice infected with
wild type and DgogB at day 4 (Fig. 6A and 6B) and at day 60
(Fig. 6C and 6D). Tissue samples from wild type-infected mice
were characterized by mild to moderate infiltration of mononu-
clear cells and polymorphonuclear leukocytes (PMN) particularly
at the surface epithelium and submucosa, minimal necrosis and
edema, and minimal pathological changes in the mucosa. In
comparison, increased colonization by DgogB was accompanied by
moderate to severe pathology with dramatic changes in the gross
morphology of the cecum due to increased influx of mononuclear
cells and PMNs, granulomatous lesions, ulceration and increased
frequency of cryptic abscesses.
From recent work, intestinal inflammation provides a selective
advantage for Salmonella by creating an environment that enhances
the pathogen’s growth and dissemination via metabolic fitness
[31,32]. To examine the inflammatory markers associated with
colonization and pathology, we measured the levels of pro- and
anti-inflammatory cytokines in the cecum and MLN by quanti-
tative RT-PCR. At day 4, expression of the NFkB target genes,
TNFa, IL1b and IL12p40 were significantly upregulated in the
cecum of DgogB-infected mice compared to wild type, while
expression of TGFb1 and the anti-inflammatory cytokines IL4 and
IL10 were similar in both groups of mice (Fig. 7A). The
expression profiles of pro- and anti-inflammatory cytokines in
the MLNs were similar in both groups of infected mice except for
MIP2 (Fig. 7B). NFkB activity is repressed by TGFb1-mediated
stabilization of IkBa [33] and the expression of TGFb1 in the
MLN from both groups of mice corresponded with an overall
lower expression of NFkB target genes compared to the cecum.
The higher expression of macrophage inflammatory protein 2
(MIP-2) chemokine in the cecum and MLN of DgogB-infected mice
is consistent with the increased recruitment of phagocytes. At day
60, the levels of IL12p40 and MIP2 remained higher in the cecum
of DgogB-infected mice (Fig. 7C) whereas the other inflammatory
markers had normalized in the MLN between both groups of
mice. Overall, these data indicate that GogB plays an important
role in dampening the host immune response and limiting tissue
destruction during Salmonella infection in the gut.
Discussion
In this study, we characterized the role of the LRR-containing
T3SS effector GogB in Salmonella pathogenesis. Due to its
similarity in the LRR domain with members of the NELs, we
hypothesized that GogB may be involved in subverting the host
ubiquitination process. We identified FBXO22 as the host cell
target of GogB that facilitates binding to host Skp1. Skp1 is an
adapter protein linking diverse F-box proteins and Cullin-1 to
form the SCF ligase complex [23]. Accordingly, we found that
GogB interacted with Skp1, which was mediated by an Fbox-like
domain in the C-terminal part of GogB. Thus, GogB could be
functioning in a similar manner to the Legionella effector AnkB
(Lpp2082) previously identified as a prokaryotic F-box protein and
to the ankyrin repeat proteins found in poxvirus that contains an
F-box motif at the C-terminal domain [12,13,14]. Whether or not
the N-terminal LRR in GogB interacts with other host cell
proteins or forms a complex with other effectors through this
domain has yet to be determined, although we did show that this
LRR domain is not necessary for targeting GogB to either Skp1 or
FBXO22, or for the downstream inhibition of NFkB activation.
Recently, one target of the SCF
FBXO22 complex was identified as
the histone demethylaase KDM4A [34]. However, another study
showed that KDM4A turnover was instead coordinated by an
SCF
FbxL4 complex [35]. Therefore, whether or not GogB is
involved in KDM4A turnover remains an open question that
could be the focus of follow up work. To our knowledge, our
report is the first to implicate a role for FBXO22 in the regulation
Figure 4. Deletion of GogB does not affect replication in cells in
vitro or acute infection of susceptible mice. A. RAW 264.7 cells
were infected with wild type Salmonella, DgogB, DgogB/pgogB-2HA,
DgogB/pgogBNT-2HA and DgogB/pgogBCT-2HA. At 20 hr post-infection,
infected cells were lysed and intracellular bacteria were enumerated.
Fold replication represents the ratio of intracellular bacteria at 20 h and
2 h. Data are the means with standard error of three separate
experiments. B. C57BL/6 mice were orally infected with a mixed
inoculum of wild type Salmonella and the DgogB strain. The
competitive index (CI) was determined in the spleen, liver and cecum
after 3 days. Each data point represents one animal and horizontal bars
indicate geometric means.
doi:10.1371/journal.ppat.1002773.g004
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described human F-box protein.
In the human F-box protein Skp2, the last 30 amino acids of the
LRR domain fold over the F-box-Skp1 interface, suggesting a
possible mechanism by which the GogB LRR may be performing
a regulatory function in the full-length protein [26]. The Skp2 F-
box has three helices, with H1 folding orthogonally to the H2-H3
anti-parallel helices that interdigitate with the C-terminus of Skp1
[26]. Structure predictions for GogB show its F-box domain to be
a combination of coiled-coils and helices. Given that the GogB F-
box was necessary for Skp1 interaction, it seems this motif may
perform a similar function to the Skp2 F-box in binding to Skp1.
In the case of FBXO22 and GogB, it is possible that both proteins
bind to Skp1 but the presence of GogB may prevent proper
Figure 5. Deletion of GogB promotes chronic colonization in Nramp
+/+ mice. Groups of 129/svImJ mice were orally infected with wild type
Salmonella or the DgogB mutant. After 4, 7, 39, or 60 days of infection, viable bacteria were recovered from organs and enumerated. Each data point
represents one animal and horizontal bars indicate geometric means. Asterisks denote significant differences between wild type and DgogB (P,0.05).
doi:10.1371/journal.ppat.1002773.g005
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FBXO22 ligase, perhaps in conjunction with
another protein(s). On this point, some of our data is consistent
with the GogB-FBXO22 interaction being dependent on another
molecule since FBXO22 co-purified with GogB only when this
effector was delivered into host cells by bacteria and not when
GogB was mixed with host cell lysates. This might implicate
another bacterial-delivered effector or host protein in the
interaction of GogB with FBXO22. Alternatively, it is increasingly
being shown that host-dependent modification of bacterial
effectors can dictate their biological function [36,37]. As such,
the GogB-FBXO22 interaction may be enhanced or stabilized by
a host-dependent modification process following translocation.
These possibilities will be the subject of work to follow.
Gut inflammation is important for colonization by Salmonella
[31,32]. A typical Salmonella infection elicits transient inflammation
during the early stages of infection but does not lead to destruction
of the intestinal epithelium [38]. The ability to elicit intestinal
inflammation is dependent, in part, on both T3SS encoded in
Salmonella and their associated effectors [39,40,41]. The SPI-1
T3SS is better known for its role in regulating the early
colonization of the intestine, whereas the SPI-2 T3SS has typically
been studied in the context of systemic infection. Although the role
of these two T3SS in distinct stages of infection may be less
disparate than previously thought, it is interesting that GogB is one
of only a few effector substrates that is delivered by both T3SS-1
and T3SS-2 systems in Salmonella [7] indicating that this protein
might be involved in regulating immune processes from an early
stage of the host-pathogen interaction.
A major finding of biological significance in this study was that
the GogB-mediated down-regulation of the host inflammatory
response during chronic mouse infection limits tissue damage and
host pathology. In the absence of GogB, mice were colonized to
greater levels especially in the chronically infected cecum
accompanied by increased inflammation and tissue damage.
Salmonella reside within macrophages in the MLN, which serves
as a reservoir for subsequent re-seeding of the liver and spleen
[42,43]. Our data on the levels of pro-inflammatory cytokine
expression at days 4 and 60 post-infection showed that inflamma-
tion was prominent only in the cecum and not in the MLN. This
might indicate that a subpopulation of DgogB Salmonella that are
able to traverse the epithelial barrier and reach the MLN, liver
and spleen retain their ability to suppress systemic host inflam-
mation possibly through the concerted action of other anti-
inflammatory effectors. The increased inflammation in gut tissue
Figure 6. Cecal colonization in DgogB-infected mice is accompanied by inflammation and tissue damage. A. Hemotoxylin-eosin-stained
cecal tissue from infected 129/svImJ mice at day 4. Images are representative of tissue from 5 mice per group, scored for pathology (B) as outlined in
Methods. C. Hemotoxylin-eosin-stained cecal tissue from infected 129/svImJ mice at day 60. D. Tissue pathology at day 60 post-infection was
quantified as described.
doi:10.1371/journal.ppat.1002773.g006
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colonization in Nramp1-positive mice by the gogB mutant supports
recent data showing that Salmonella takes advantage of intestinal
inflammation for metabolic fitness by using tetrathionate as a
respiratory electron acceptor [31]. What was unclear however was
how the pathogen might temper this host inflammatory response
once infection is established to limit the tissue damage that arises
from an unchecked immune response. The acquisition of the type
III effector GogB with anti-inflammatory activity appears to
benefit Salmonella by limiting host tissue damage during of
colonization, while maintaining a degree of inflammation that
supports competition with the host microbiota. In this way, GogB
appears to balance the pathogen’s short-term need for inflamma-
tion-enhanced colonization while moderating this immune
response to limit tissue damage in the longer term.
Materials and Methods
Ethics statement
All experiments with animals were conducted according to
guidelines set by the Canadian Council on Animal Care. The local
animal ethics committee, the Animal Review Ethics Board at
McMasterUniversity,approvedallprotocolsdeveloped forthiswork.
Bacterial strains and cell culture
All bacterial strains used in this study are listed in Table S1. S.
enterica serovar Typhimurium strain SL1344 was used in this study
and all mutant strains were derivatives of Salmonella SL1344. The
generation of the gogB mutant was described previously [7].
Salmonella was grown in Luria-Bertani (LB) broth or on agar plates
with appropriate antibiotics. E. coli strain BL21 (DE3) was used for
expression and purification of recombinant GST-tagged GogB
and truncated mutants. RAW264.7 and HeLa cells were routinely
cultured in Dulbecco’s Modified Eagle Medium (DMEM)
supplemented with 10% fetal bovine serum (FBS) and grown at
37uC and 5% CO2.
Plasmid construction
The plasmids and primers used in this study are listed in Table
S1. The generation of the plasmid pWSK129-gogB-2HA encoding
a hemagglutinin (HA)-tagged gogB that is expressed under its
native promoter was described previously [7]. To generate the
epitope-tagged mutant gogB-NT1–253, the region encoding amino
acid residues 1 to 253 of gogB was PCR amplified using the plasmid
pWSK129-gogB-2HA as a template and the product was digested
with SalI and BglII and cloned into the corresponding sites of
Figure 7. Expression of inflammatory markers in the cecum and MLN of infected mice. 129svImJ mice were orally infected with wild type
or DgogB Salmonella. At day 4 post-infection (A and B) and day 60 post-infection (C and D), RNA was extracted from the cecum and MLN and the
relative mRNA levels of the inflammatory markers shown were determined by RT-PCR. Relative expression levels were normalized to 18S RNA and
expressed as log-transformed mean fold change in expression with standard errors from 5 experiments. Asterisks denote significant difference from
mice infected with wild type and DgogB Salmonella (P,0.05).
doi:10.1371/journal.ppat.1002773.g007
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Strand-overlap PCR was used to construct the HA-tagged mutant
gogB-CT254–497. The gogB native promoter and the secretion signal
sequence encoding the first 29 amino acids at the N-terminus were
amplified by PCR. A second PCR was performed to amplify the
gogB region encoding the C-terminus from amino acid residues 254
to 497. The resulting products were fused together by a third
round of PCR, digested with SalI and BglII and cloned into the
corresponding sites of pWSK129-2HA. The conserved leucine
(L270) and proline (P271) in GogB, and L47 and P48 in GogB-
CT254–497 were substituted with alanine residues using the
QuikChange site-directed mutagenesis kit (Stratagene) and the
plasmids pWSK129 gogB-2HA and pWSK129 gogBCT254–497-
2HA as templates. In-frame deletion of the identified F-box motif
in GogB was done by strand-overlap PCR in which the upstream
gogB promoter and the region encoding amino acid residues 1 to
264 were amplified. A separate PCR was performed to amplify the
region spanning amino acid residues 353 to 497. The resulting
products were fused together by PCR, digested with SalI and BglII
and cloned into the corresponding sites of pWSK129-2HA. The
plasmids encoding epitope-tagged GogB and GogB mutants were
transformed into DgogB. An in-frame marked deletion of gogB and
sspH2 or sseL to produce a double gene knockout strain was
performed by lambda red recombination. To generate GST-
tagged gogB and the truncated mutants gogBNT1–253 and
gogBCT254–497, the corresponding regions were amplified by
PCR using the pWSK129 templates described above (Table S1).
The PCR products were digested with SalI and BamHI and cloned
into the corresponding sites of the plasmid pGEX-6P-1.
Gentamicin protection assays
RAW264.7 or HeLa were seeded into 24-well plates at 5610
5
cells/ml 18 hr prior to infection. Overnight bacterial cultures were
opsonized with 20% normal human serum and used to infect
macrophages at a multiplicity of infection (MOI) of 10 or 20
bacteria per cell. To prepare highly invasive bacteria for infection
of HeLa cells, overnight cultures were subcultured in LB and
grown for 2 hr at 37uC with shaking. Bacteria were washed with
PBS and resuspended in DMEM/FBS and used to infect epithelial
cells at MOI of 10 or 20 bacteria per cell. After 30 min of
infection, the media was replaced with DMEM/FBS containing
100 mg/ml gentamicin to kill extracellular bacteria and incubated
for 1.5 hr. At 2 hr post-infection (PI), cells were lysed with PBS/
1% Triton X-100 to release intracellular bacteria and the number
of colony-forming units (CFU) was determined by plating serially-
diluted bacteria on LB agar plates supplemented with 50 mg/ml
streptomycin. Infected cells were washed with PBS and incubated
with media containing 10 mg/ml gentamicin for longer time
points. Bacterial numbers were expressed as the ratio of
intracellular CFU at 20 h to 2 h.
Protein purification
The procedure for purification and solubilization of recombi-
nant GogB, GogB-NT and GogB-CT GST fusion proteins was
performed as described previously with several modifications [44].
E. coli BL21 (DE3) were transformed with plasmids encoding GST
alone or GST fusion proteins and grown in 1 liter LB with
100 mg/ml ampicillin to OD600,0.7 at 37uC. Protein expression
was induced with 0.1 mM isopropyl b-D-1-thiogalactopyranoside
(IPTG) for 24 hr at 16uC. Cells were harvested, resuspended in
lysis buffer containing 40 mM Tris pH 8.0, 500 mM NaCl, 1 mM
EDTA, 50 mg/ml lysozyme and protease inhibitor cocktail
(Roche). DTT was added to a final concentration of 5 mM then
cells were lysed by sonication. A final concentration of 1% Triton
X-100 was added to the lysate and incubated on ice for 20 min.
The lysates were clarified by centrifugation and the supernatant
was mixed with glutathione sepharose 4B matrix beads (GE
Healthcare) previously equilibrated with 40 mM Tris pH 8.0,
500 mM NaCl (TBS). The mixture was incubated overnight at
4uC in a rotator-shaker then the column was washed with ten bed
volume of TBS. Proteins were eluted by incubating beads
overnight with elution buffer (40 mM Tris pH 8.0, 500 mM
NaCl, 1% Triton X-100, 5 mM DTT and 50 mM reduced
glutathione) at 4uC. Proteins were dialyzed against TBS with 1%
Triton X-100, 5 mM DTT to remove excess glutathione and
concentrated using an Amicon centrifugal filter (Millipore).
Alternatively, GST beads coupled to recombinant proteins were
washed with TBS and stored at 4uC in storage buffer (40 mM Tris
pH 7.5, 500 mM NaCl, 1% Triton X-100, 5 mM DTT, 10%
glycerol) until further use in GST pull-down assays.
GST pull-down assays and in vivo co-
immunoprecipitation
Purified recombinant GST-tagged GogB, GogB-NT, GogB-CT
or GST were coupled to GST affinity beads. HeLa or RAW264.7
cells were lysed with lysis buffer containing 40 mM Tris pH 8,
200 mM NaCl, 1% Triton X-100 and protease inhibitor cocktail
(TBST). Lysates were clarified by centrifugation and the super-
natant was incubated with GST affinity beads overnight at 4uC
with end-on-end mixing. The beads were washed under stringent
conditions and resuspended in SDS sample buffer. Bound proteins
were resolved by SDS-PAGE and analyzed by Western blot. Cell-
based co-immunoprecipitation assays were performed by infecting
HeLa or RAW264.7 cells with wild type SL1344, DgogB or a gogB
mutant strain containing a plasmid that encodes HA-tagged gogB
or gogB mutants. At 20 h post-infection, cells were washed with
PBS and lysed with TBST. Lysates were incubated with anti-HA
affinity beads (Roche) overnight at 4uC with end-on-end mixing.
The beads were washed under stringent conditions and resus-
pended in SDS sample buffer. Bound proteins were resolved by
SDS-PAGE and analyzed by Western blot.
Luciferase reporter assays
RAW264.7 or HeLa cells were seeded into 96-well plates and
after 16 h, cells were transfected with the reporter plasmid
pNFkB-luc and the control plasmid pCMVbgal (Clontech) using
Fugene HD reagent (Roche) according to manufacturer’s recom-
mendations. Twenty-four hours after transfection, cells were
infected as described above. At 20 h post-infection, luciferase
activity was measured using the Luc-Screen System (Applied
Biosystems) and b-galactosidase levels were measured using
Galacto-star system following the manufacturer’s protocols.
Luciferase signals were normalized to b-galactosidase levels and
to colony forming units (CFUs) enumerated for each strain at
20 hr post-infection. Data were expressed as fold activation
relative to cells infected with wild-type Salmonella containing an
empty plasmid (mean 6 SEM, n$3).
Skp1 knockdown in HeLa cells
The short-interfering RNA (siRNA) sequence used to knock-
down Skp1 expression was published previously [13]. HeLa cells
were seeded into 96 well plates and after 16 h, cells were co-
transfected with 2 pmol of the Skp1 siRNA (GCA AGU CAA
UUG UAU AGC AGA A and UUC UGC UAA UAC AAU
UGA CUU GC), the reporter plasmid pNFkB-luc and the control
plasmid pCMVbgal using Lipofectamine 2000 transfection
reagent (Invitrogen). For control experiments, HeLa cells were
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plasmids. At 24 h post-transfection, cells were infected at an MOI
of 20 and the luciferase activity was measured as described above.
Western blot analysis of HeLa cell lysates was performed to
confirm knockdown of Skp1 expression using anti-Skp1 antibody
and anti-GAPDH as loading control. For co-immunoprecipitation
assays, HeLa cells were seeded into 24 well plates and after 16 h,
cells were transfected with 80 pmol Skp1 or control siRNA using
Lipofectamine 2000 reagent for 24 hr. Cells were then infected
with either DgogB or DgogB complemented with pgogB-2HA at an
MOI of 20. At 20 hr post-infection, cells were lysed and mixed
with anti-HA affinity beads overnight at 4uC. Bound protein
complexes were resolved by SDS-PAGE and analyzed by Western
blot using rabbit anti-Skp1, mouse anti-FBXO22, and HRP-
conjugated rat anti-HA. Lysates from infected cells were
normalized by protein content and analyzed by Western blot to
determine knockdown of Skp1 expression. Mouse anti-GAPDH
antibodies were used as loading control.
Measurement of IL1b
RAW264.7 cells were seeded in 96 well plates and infected as
described above. At 20 h post-infection, the culture supernatants
were assayed for interleukin-1-beta (IL1b) levels using an ELISA
kit (eBioscience). Data was expressed as the average IL1b
concentration (pg/mL) normalized to CFUs obtained for each
strain at 20 h post-infection. Assays were done in three separate
experiments (n=3). Statistical analyses were performed using a
two-tailed student’s t test.
IkBa degradation assays
RAW264.7 cells were infected with wild type SL1344 and the
DgogB strain as described above. At various time points, cells were
lysed with PBS/1% Triton X-100 and the lysates were normalized
for total protein content. Proteins were resolved by SDS-PAGE
and IkBa levels were analyzed by Western blot. Immunoblotting
was performed by resolving proteins or cell lysates in 8 or 10%
SDS-PAGE and transferring to a PVDF membrane. Blots were
analyzed using the following antibodies: rabbit anti-Skp1 (Novus
Biologicals), mouse anti-FBXO22 (Abcam), rabbit anti-b-actin
(Imgenex), mouse anti-ubiquitin FK2 (Enzo Life Sciences), rabbit
anti-GST (Bethyl Laboratories), rat anti-HA-HRP (Roche),
rabbit anti-IkBa (Calbiochem), and mouse anti-GAPDH (Novus
Biologicals).
IkBa ubiquitination assay
RAW264.7 cells were seeded in 6 well plates at 2610
6 cells/well
and infected with wild type SL1344, DgogB/pgogB, DgogB/pgogB
D264–352 and DgogB strains at an MOI of 20 bacteria per cell in
the presence of 10 mM MG-132 (Sigma) to inhibit proteasome
degradation of ubiquitinated IkBa. Control wells were infected
with the same strains in the presence of 0.2% DMSO. At 30 min
post-infection, cells were washed with PBS and fresh media
containing 10 mM MG-132 was added to the infected cells and
incubated for 3.5 hr. Cells were then lysed with buffer containing
40 mM Tris pH 7.5, 150 mM NaCl, 1% Triton X-100, 1 mM
EDTA, 10 mM MG-132, 10 mM N-ethylmaleimide and protease
inhibitor cocktail (Roche). Lysates were normalized for protein
content and mixed with IgA Dynabeads (Invitrogen) previously
coupled to rabbit anti-IkBa following manufacturer’s instructions.
The mixtures were incubated overnight at 4uC with end-on-end
mixing. Beads were then washed three times with TBS/1% Triton
X-100 followed by TBS and resuspended in SDS sample buffer.
Protein samples were resolved by SDS-PAGE and analyzed by
Western blot using HRP-conjugated mouse anti-ubiquitin FK2
(Enzo Life Sciences) and rabbit anti-IkBa (Calbiochem).
Animal infections and competitive infection assays
Protocols for the infection of experimental animals were
approved by the Animal Research Ethics Board at McMaster
University and in accordance to guidelines from the Canadian
Council on the Use of Laboratory Animals. Competition assays
were performed as previously described [45]. Groups of five female
C57BL/6 mice were orally inoculated with a mixed inoculum of
wild type Salmonella and DgogB resistant to chloramphenicol
(,1610
6 CFU per strain). At 72 h post-infection, the bacterial
loads were determined by platingtissue homogenates from the liver,
spleen,and cecum.The competitive index (CI) was computed as the
ratio of mutant/wild type CFU in the output versus input. 129/
svImJ mice that are resistant to Salmonella due to a homozygous
Nramp
r allele were used as experimental animals for chronic
Salmonella infections. Groups of five female 129/svImJ mice were
orally inoculated with 1610
7 CFU of either wild type Salmonella or
the DgogB strain. After 4, 7, 39, and 60 days of infection, bacterial
loads were determined by plating tissue homogenates of the liver,
spleen, mesenteric lymph nodes (MLN), and cecum. In some
experiments, mice were immunosuppressed prior to infection using
dexamethasone in the drinking water as described previously [46].
Data were plotted as geometric means of log-transformed CFU per
mg of tissue. Statistical analyses were performed using a nonpara-
metric, two-tailed Mann-Whitney t test.
Histopathological analyses
A portion of the distal cecal tip of experimental animals was
fixed in 4% paraformaldehyde (PFA) for 72 h, then transferred to
70% ethanol for 48 h prior to paraffin embedding, sectioning, and
hematoxylin-eosin staining. Methodology for histology scoring was
performed as previously described [47].
Real-time PCR (RT-PCR)
Nramp
r mice were orally infected with 10
7 CFU of wild type and
DgogB Salmonella. At day 4 post-infection, total RNA was extracted
from the cecum and MLN using Trizol reagent (Invitrogen)
following the manufacturer’s protocol. After determining the
purity of the extracted RNA, 5 mg of RNA was reverse-transcribed
to cDNA using random hexamers and Superscript III reverse
transcriptase (Invitrogen) according to manufacturer’s protocols.
RT-PCR was performed in a Lightcycler 480 (Roche) using the
Lightcycler 480 SYBR I Master Mix (Roche) and specific primers
listed in Table S2. RT-PCR was performed in triplicate with the
following settings: pre-incubation at 95uC for 5 min and 60 cycles
of amplification at 95Cu for 10 s, 55uC for 10 s, and 72uC for 20 s.
Melting curve analysis was done at 95uC for 5 s, 65uC for 1 min
and at 97uC followed by cooling to 40uC for 10 s. Data analysis
was performed using the Lightcycler 480 version 1.5 software
(Roche). Relative fold change in expression was calculated using
the formula based on the Pfaffl method: Ratio=[(Etarget)
DCt target
(control-treated)]/[(Eref)
DCt ref (control-treated)] where E is the primer
efficiency determined for specific primers and DCt is the difference
in the mean crossing thresholds from control uninfected and
infected mice. 18S rRNA was used as the reference gene.
Supporting Information
Figure S1 Secretion assays of GogB-NT and GogB-CT.
The DgogB Salmonella containing pgogB-2HA,p gogBNT-2HA and
pgogBCT-2HA were grown in SPI-2 inducing media (LPM) at
pH 5.8 for 5 h at 37uC. Cells were harvested and the secreted
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by SDS-PAGE and analyzed by Western blot using mouse anti-
HA antibodies. Antibodies to DnaK were used as loading control.
(TIF)
Figure S2 Immunosuppression reduces the bacterial
load of the gogB mutant in the cecum. A. Groups of 129/
svImJ mice were pretreated with dexamethasone or not, and then
orally infected with DgogB mutant Salmonella. At day 4 after
infection mice were sacrificed and the bacterial load in the cecum
was determined by serial dilution of tissue homogenates. Each data
point represents one animal and horizontal bars indicate
geometric means. B. Groups of 129/svImJ mice were pretreated
with dexamethasone and then infected with either wild-type
Salmonella or the DgogB mutant. Bacterial load was determined in
the cecum at day 4 after infection. Each data point represents one
animal and horizontal bars indicate geometric means.
(TIF)
Table S1 List of plasmids and strains used in this
study.
(DOC)
Table S2 List of oligonucleotides used in this study.
(DOC)
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